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Background: A myocardial bridge (MB) is a band of myocardium covering a coronary artery segment, typically
located in the left anterior descending coronary artery (LAD). Bridged segments of the coronary artery are isolat-
ed from the inﬂuence of perivascular adipose tissue. The aims of this study were to investigate the relationship
between MBs and atherosclerosis in bridged LAD segments and to evaluate whether perivascular adipose tissue
is involved in this relationship.
Methods:MBs were identiﬁed in the coronary arteries of patients referred for diagnostic cardiac CT. The calcium
score of MBs of the LAD or, in patients without LAD-MBs, of a corresponding LAD segment at the same distance
from its origin and over the same length was measured.
Results:Of 128 patients, 56 (44%) had in total 73MBs. ThemeanMB length was 22±14 mmand themedianMB
thickness was 0.8 mm (interquartile range 0.3–2.1 mm). MBs in the LAD were present in 40 patients (31%). The
calcium score was 0 in 95% of the LAD segments with MBs compared with 52% of the corresponding LAD
segments without MBs. The association between LAD-MBs and calcium score (OR 0.06, 95% CI 0.01–0.25) was
not inﬂuenced by age and gender, but was attenuated by local perivascular adipose tissue thickness (OR 0.35,
95% CI 0.04–2.70).
Conclusions: Coronary artery segments covered with an MB have a lower calcium score than segments without
an MB. The association between MBs and calcium scores was inﬂuenced by local perivascular adipose tissue
thickness.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The coronary arteries usually run an epicardial course and are sur-
rounded by coronary perivascular adipose tissue. A variant of coronary
artery anatomy is themyocardial bridge (MB), whereby part of the cor-
onary artery runs through the myocardium. The reported prevalence of
MBs varies between 5% and 86% [1–3].MBs aremost common in the left
anterior descending artery (LAD) [2]. Interestingly, coronary artery
segmentswithMBs have been found to be free of atherosclerotic plaque
in autopsy [3–5] and CT [6–9] studies, although in the CT studies noatare Foundation, Monaco and
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Ltd. All rights reserved.comparable control groups or control segments were investigated.
Hemodynamic factors have been proposed to explain the absence of
atherosclerosis in bridged coronary artery segments [10], but an
alternative view is that bridged coronary arteries are protected
from the inﬂuence of perivascular adipose tissue by the overlying
myocardium.
Most arteries are directly surrounded by perivascular adipose tissue,
and the diffusion of pro-inﬂammatory cytokines and adipokines may
locally affect the metabolism of the coronary artery wall by inducing
endothelial dysfunction, monocyte chemotaxis, and smooth muscle
cell proliferation [11–13]. Indeed, it could be hypothesized that perivas-
cular adipose tissue stimulates atherosclerotic plaque formation from
outside to inside.
Abdominal obesity is a risk factor for the development of cardio-
vascular diseases by inducing systemic metabolic disturbances, such
as inﬂammation, insulin resistance, dyslipidemia, and hypercoagul-
ability [14]. This is thought to be a consequence of adipose tissue dys-
function, which is characterized by the secretion of pro-inﬂammatory
cytokines and adipokines, such as tumor necrosis factor-α (TNF-α),
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the inhibitor of ﬁbrinolysis plasminogen activator inhibitor-1 (PAI-
1) [15].
We hypothesized that sections of coronary artery covered by anMB
do not show atherosclerotic changes and that this might be due to the
lack of exposure to perivascular adipose tissue at these sites. Therefore,
the aims of the present studywere to compare the extent of atheroscle-
rosis, measured as coronary calcium, in coronary artery segments with
or without MBs in patients referred for angina pectoris, and to investi-
gate the potential role of perivascular adipose tissue in this relationship.
2. Methods
2.1. Study participants and design
Consecutive patients (n=128) referred to the UniversityMedical Center Utrecht, The
Netherlands, for diagnostic coronary angiography for stable or unstable angina pectoris
were included in this cross-sectional study. Inclusion criteria were age 50–70 years and
stable sinus rhythm. Patients who had previously undergone PTCA or CABG, or who had
serum creatinine levels>140 μmol/l or known iodine-based contrast allergywere exclud-
ed. The medical ethics committee approved the study and all participants gave their
written informed consent.
Medical history was obtained using a standardized health questionnaire. Height,
weight, blood pressure, and the volume of epicardial adipose tissue [16] were measured.
Epicardial adipose tissue volumewas deﬁned as the adipose tissue between the ventricu-
lar wall and the visceral epicardium. Fasting bloodwas sampled tomeasure lipid, glucose,
and creatinine levels. Metabolic syndrome was diagnosed according to the Adult Treat-
ment Panel III (ATPIII) criteria as the presence of at least three or more metabolic abnor-
malities [17]. Because waist circumference was not available, a BMI ≥30 kg/m2 was
considered indicative of obesity [18]. The number of coronary arteries (RCA, LAD, and
RCX) with ≥50% stenosis was evaluated on multiple conventional coronary angiography
projections to determine whether subjects had 0-, 1-, 2-, or 3-vessel disease [19]. Left
main artery stenosis was scored as 2-vessel disease [19].
2.2. CT technique and image analysis
MBs were identiﬁed on retrospectively ECG-gated diagnostic cardiac CT scans
acquired with a 64 detector-row CT scanner (Brilliance 64, Philips Medical Systems,
Cleveland, OH, USA). Scan duration was 7–10 s. Standard coronary CT angiography
protocols were used, including the use of intravenous beta-blockers for patients with
a heart rate >65 beats/min (unless contraindicated), and images were acquired
when the subject held his/her breath during inspiration. Imaging parameters were
slice collimation of 64×0.625 mm, gantry rotation time of 420 ms, tube voltage of
120 kVp, tube current of 900 mAs. The contrast agent iopromide (Bayer-Schering AG,
Berlin, Germany) was injected intravenously (1.6–2.0 g iodine/s depending on the
patient's body weight). The most motionless phase of the cardiac cycle, usually at
70–80% of the R–R interval, was chosen for analysis. The window settings were adjust-
ed to enable optimal visualization of soft tissue.
2.3. Identiﬁcation and measurement of MBs
MBs, deﬁned as a coronary artery segment covered bymyocardium,were detected on
contrast-enhanced scans. Although limited spatial resolutionmakes it difﬁcult to visualize
MBs b0.3 mm thick [20], we included these bridges in the analyses, because the absence of
atherosclerosis in thinMBswould be strong evidence in favor of our hypothesis. Measure-
ments were performed on curved planar reformation views. The length of the MB was
deﬁned as the length of the intramyocardial course of the coronary artery segment. The
thickness of an MB was measured at the widest part of the overlying myocardium
(Fig. 1). If the thickness of a MB could not be measured (b0.3 mm), it was given the
value of 0.3 mm.
2.4. Measurement of calcium score in coronary artery segments
Coronary artery calcium imaging was performed using multislice CT scanning.
Non-contrast scans, reconstructed with 3-mm-slice thickness and an increment of
1.5 mm, were acquired during a single breath-hold. The Agatston calcium score was
chosen as measure of atherosclerosis and was calculated with dedicated software for
calcium scoring (ImageXplorer) [21]. For total calcium score, all regions with a density
>130 HU and a minimum size of 0.5 mm2 were identiﬁed as potential calciﬁcations.
The peak density in HU and the area in mm2 in each selected region were calculated
and multiplied by a weighting factor [22].
The calcium score within the LAD was also calculated. To compare coronary artery
segmentswith andwithoutMBs, an area of interestwas selected for each subject. Subjects
with LAD-MBs (n=40) were randomly paired with subjects without LAD-MBs (n=88).
The calcium score of the intramyocardial artery segment wasmeasured in patients with a
LAD-MB and in a section of the LAD at the same distance from the origin of the left
coronary artery and over the same length in subjects without a LAD-MB (Fig. 1). Inaddition, the presence of atherosclerotic plaque in the same bridged and matched LAD
segments was determined.
2.5. Measurement of perivascular adipose tissue thickness
The thickness of perivascular adipose tissue was measured in the region of interest
in the LAD as the mean of two measurements from the myocardium to the pericardium
at the site of minimum and maximum thickness, respectively. Measurements where
performed on curved planar reformation views. Segments with MBs were not in
contact with perivascular adipose tissue.
2.6. Data analyses
Analyses were performed with SPSS 18. Associations between the presence of an
MB (yes/no) and age, gender, and cardiometabolic risk factors were analyzed with
logistic regression analysis. Differences in the length and thickness of an MB with
respect to its location were calculated and tested with Kruskal–Wallis test.
Differences in the calcium score of bridged and matched segments (0 versus >0) in
patients with or without MBs were compared and signiﬁcance was tested with
Chi-square. The relationship between MBs and calcium scores in the region of interest
was analyzed with univariate and multivariate logistic regression modeling. The calcium
score in the region of interest (0 or >0)was used as dependent variable and the presence
of an MB (yes/no) was used as independent variable. Different models were constructed
to adjust for potential confounding factors, such as age and gender (model 2), calcium
score (model 3), and local perivascular adipose tissue thickness (model 4).
In patients without MBs, perivascular adipose tissue was used as independent var-
iable in linear regression analyses with local calcium score as outcome. Calcium scores
were log-transformed (LN(calcium score +1)) because scores were not normally dis-
tributed in the regions of interest.
3. Results
3.1. Baseline characteristics of study population
In 56 of the 128 subjects (44%), 73 MBs were detected, and 44 of
these MBs (in 43 subjects) had a thickness ≥0.3 mm. In 40 (31%) sub-
jects, MBs of the LAD were detected, and 27 of these MBs had a thick-
ness ≥0.3 mm.
The characteristics of patients with (n=40) and without (n=88) a
LAD-MBwere comparable (Table 1), except that patientswith a LAD-MB
had more severe coronary artery disease, as determined with conven-
tional angiography, with≥2 vessel disease being detected in 23 patients
with a LAD-MB (58%) compared with 32 patients without a LAD-MB
(36%) (p=0.03). Total calcium scores were not statistically signiﬁcantly
different between the groups with or without a LAD-MB (median 135,
interquartile range 35–622 versus median 184, IQR 45–502, respective-
ly; p=0.76). In addition, the prevalence of LAD stenosis≥50%was sim-
ilar in the two groups, occurring in 21 (53%) and 46 (53%) patients with
and without a LAD-MB, respectively (p=0.98). The same was true
for the LAD calcium score: median score 61 (IQR 19–225) versus 107
(IQR 15–242), respectively (p=0.35). The mean length of LAD-MBs
was 21.7±14.9 mm and the median thickness was 0.9 mm (IQR
0.3–2.2 mm) (Fig. 2). The mean length of diagonal branch MBs was
19.8±10.2 mm with a median thickness of 0.8 mm (IQR 0.3–2.1 mm),
and the mean length of marginal obtusis MBs was 24.0±14.0 mm
with a median thickness of 0.9 mm (IQR 0.1–1.7 mm). There were no
statistically signiﬁcant differences in the length and thickness of MBs
in the LAD, diagonal branch, or marginal obtusis branch (p=0.8 and
p=0.5 respectively).
3.2. Relation between LAD-MBs and local atherosclerosis
Out of the 40 subjectswith a LAD-MB, 2 (5%) had a calcium score>0
in the bridged region, whereas 42 of the 88 subjects without a LAD-MB
(48%) had a calcium score >0 in thematched LAD segment (pb0.0001)
(Table 2a). Atherosclerotic plaque in bridged LAD segments was less
common than it was in corresponding LAD segments without MBs,
with plaque being detected in 2 patients (5%) versus 44 patients
(50%), respectively (pb0.0001).
The presence of an MB compared with the absence of an MB in the
LAD was associated with a lower calcium score in the bridged segment
Fig. 1. Detection of myocardial bridges (MBs), measurement of MB length and thickness, and measurement of calcium score of coronary artery segments with and without an MB.
The following MB properties were measured: distance to origin (A), length (B), and thickness (C). Calcium score was measured in bridged coronary artery segments and corre-
sponding segments in subjects without an MB. In subjects without an MB (D), calcium score was measured in a segment at the same distance to origin and over the same length
as in subjects with an MB (E). (Selected regions are indicated with a yellow arrow.) Calcium score was measured in the region of interest (F) (G). (Blue: regions with a density of
>130 Houndsﬁeld Units (HU).) (Yellow: selected region). Perivascular adipose tissue thickness was measured in the regions of interest (H).
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tially change after adjusting for age, gender, or total coronary calcium
score, and after exclusion of patients with an MB with a thickness
b3 mm (OR 0.08, 95% CI 0.02–0.37).
The inverse association between MBs and local calcium score was
attenuated after adjusting for local perivascular adipose tissue thickness
(OR 0.35, 95% CI 0.04–2.70). Themean thickness of perivascular adipose
tissue in the region of interestwas signiﬁcantly associatedwith the local
coronary calcium score permillimeter in the 88 subjects without anMB
(β adjusted for age and gender (OR 0.21, 95% CI 0.07–0.34)).
3.3. Determinants of presence of myocardial bridges at any location
The presence of an MB at any location was not associated with age
(per year OR 1.00, 95% CI 0.95–1.07), male gender (OR 1.60, 95% CI
0.74–3.47), or other risk factors for cardiovascular disease, such as
smoking, diabetes, BMI, LDL-cholesterol, triglycerides, epicardial
adipose tissue volume, and presence of the metabolic syndrome
(Table 3). Moreover, the extent of coronary artery disease, expressed
as the number of diseased vessels, total calcium score, and calcium
score of the LAD, was also not associated with the presence of an MB.
4. Discussion
In this cross-sectional study of patients referred for investigation of
stable or unstable angina pectoris, coronary artery segments covered
with an MB had a lower calcium score compared with segments
without an MB. The characteristics of patients with and without anMB of the LAD were comparable. The inverse association between
MBs and local calcium scores was independent of age, gender, and
total coronary artery calcium score, but was inﬂuenced by the thickness
of local perivascular adipose tissue.
The absence of atherosclerosis in coronary artery segments covered
by an MB has been reported in post-mortem and imaging studies
[1,3,5–9,23]. By comparing bridged LAD segments to matched control
segments, we could conﬁrm that the absence of atherosclerosis is due
to the MB and is not a random observation. This is in line with earlier
ﬁndings of studies investigating the severity of atherosclerosis relative
to the distance from the ostium in groups with and without MBs
[5,23]. Moreover, although this study was only hypothesis generating,
we demonstrated that perivascular adipose tissue has a role in the
association between MBs and atherosclerosis.
In a post-mortem study it was shown that the intima of bridged LAD
segments is thinner, indicating less atherosclerotic transformation, than
that of comparable segments of coronary arteries without an MB [4].
Furthermore, the extent of atherosclerosis in each subsequent LAD
cross-section is less in LAD segments with an MB than in segments
without an MB [5,23]. CT studies have shown that bridged segments
are less affected by, or are even free of, atherosclerosis [7,9,20], although
corresponding segments without MB were not evaluated. An ultra-
sound study revealed atherosclerotic plaque in 9.5% of bridged coronary
artery segments comparedwith 81.5% of corresponding segmentswith-
out an MB [24].
The mechanism by which bridged coronary artery segments are
protected against atherosclerosis remains to be elucidated. That the
association between MBs and local calcium scores changed after
Table 1
Patient characteristics.
All cases
N=128
No (LAD) MB
N=88
(LAD) MB
N=40
Age (years) 61±6 61±5 61±6
Male gender, n (%) 89 (70) 59 (67) 30 (75)
Current smoking, n (%) 42 (32) 29 (32) 13 (32)
Diabetes mellitus, n (%) 24 (19) 17 (19) 7 (18)
Stable angina pectoris, n (%) 100 (78) 68 (77) 32 (80)
History of unstable angina pectoris, n (%) 8 (6) 5 (6) 3 (8)
History of myocardial infarction, n (%) 29 (23) 21 (23) 8 (20)
Body mass index (kg/m²) 28±4 28±4 27±4
Systolic blood pressure (mm Hg) 151±22 151±22 152±24
Diastolic blood pressure (mm Hg) 81±13 81±12 81±15
Glucose (mmol/l) 5.8 (5.2–6.8) 5.8 (5.2–6.9) 5.8 (5.1–6.6)
Total cholesterol (mmol/l) 4.6±1.2 4.5±1.1 4.9±1.2
LDL-cholesterol (mmol/l) 2.6±1.0 2.5±1.0 2.7±1.1
Triglycerides (mmol/l) 1.5 (1.1–2.1) 1.5 (1.0–2.1) 1.4 (1.1–2.4)
HDL-cholesterol (mmol/l) 1.3±0.3 1.3±0.3 1.3±0.4
Metabolic syndrome n (%) 55 (43) 37 (42) 18 (45)
Medication
Blood-pressure lowering agents, n (%) 115 (90) 78 (89) 37 (93)
Lipid-lowering agents, n (%) 100 (78) 65 (74) 35 (88)
0 vessel disease 19 (15) 14 (16) 5 (13)
1-vessel disease 54 (42) 42 (48) 12 (29)
2-vessel disease 37 (28) 20 (23) 17 (43)
3-vessel disease 18 (14) 12 (14) 6 (15)
Stenosis >50% of the LAD, n (%) 67 (52) 46 (52) 21 (53)
Epicardial adipose tissue volume (cm3) 110±44 113±46 103±39
Local perivascular adipose tissue (mm) – 9.0±3.2 0
Calcium score of the LAD (Agatston) 92 (16–232) 107 (15–242) 61 (19–225)
Total calcium score (Agatston) 181 (37–544) 184 (35–622) 135 (45–502)
Presence of MB:
No MB 72 (56) 72 (82) 0 (0)
MB (LAD), n (%) 40 (30) 0 (0) 40 (100)
MB (1st diagonal branch), n (%) 5 (3) 2 (2) 3 (5)
MB (2nd diagonal branch), n (%) 4 (2) 3 (3) 1 (3)
MB (1st marginal obtusis branch), n (%) 13 (10) 9 (10) 4 (10)
MB (2nd marginal obtusis branch), n (%) 8 (6) 7 (8) 1 (3)
MB (intermediate branch), n (%) 2 (2) 1 (1) 1 (3)
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adipose tissue inﬂuences this association. There is more perivascular
adipose tissue at sites of atherosclerosis [25], and this tissue can secrete
pro-inﬂammatory adipokines and cytokines [26]. In vitro, adipose
tissue-conditioned medium induces the adhesion of monocytes to
endothelial cells and the migration of monocytes [11,12]. In mice,
perivascular adipose tissue has been found to promote the migration
of macrophages towards the vascular wall [27]. As perivascular adipose
tissue does not come into contact with the vascular wall if there is an
MB, the latter may protect the vascular wall against proinﬂammatoryFig. 2. Length and maximal thickness of myocardial bridges (MBs). Boxplot depicting MB
length (left y-axis) and MB thickness (right y-axis). LAD: left anterior descending artery;
DIAG diagonal branches; MO: marginal obtusis branches of the circumﬂex coronary
artery.cytokines and adipokines secreted by perivascular adipose tissue and
thus inhibit the atherosclerotic process.
An increase in shear stress at the site of an MB has been proposed
as explanation for the decrease in atherosclerosis [10,28]. Endothelial
cells beneath an MB are spindle shaped, indicating that they are sub-
jected to high shear stress, whereas endothelial cells in other regions
show a polygonal distribution, indicating that they are subjected to
low shear stress [10]. An increase in shear stress is thought to hinder
monocyte adhesion and lipid transfer across the vascular wall. An ar-
gument against the role of hemodynamic forces is that endothelial
cell function is impaired at the site of an MB [24], and endothelial dys-
function is associated with a high intravascular pressure. Enhanced
lymphatic drainage caused by compression during systole has recent-
ly been proposed as an alternative explanation for the reduced ath-
erosclerotic burden in bridged segments [29]. Moreover, coronary
artery segments proximal to an MB are affected more by atheroscle-
rosis than are proximal segments in subjects without MB [5]. Intra-
vascular pressure is higher in segments proximal to an MB than in
the bridged segment itself [30], and increased pressure on the vascu-
lar wall and non-laminar ﬂow give rise to advanced plaque [5,23,31].
The prevalence of MBs is high in subjects with a history of myocardial
infarction (46%), and MB thickness is greater in these subjects than in
subjects without a history of myocardial infarction [5]. It can be con-
cluded that MB thickness is associated with the extent of atheroscle-
rosis in the coronary artery segment proximal to the MB. Owing to
the low occurrence of calciﬁed plaque in bridged segments, we
were not able to evaluate the association between MB thickness and
atherosclerosis in the present study.
Table 2
Calcium content in segments of the left anterior descending (LAD) coronary artery with
a myocardial bridge (MB) and corresponding regions without an MB.
a: Calcium score in LAD segments with an MB and in LAD segments without an MB
Calcium score*: 0.0 0.1–10.0 10.0–120.0
No myocardial bridge of the LAD 46 (52%) 24 (27%) 18 (21%)
Myocardial bridge of the LAD 38 (95%) 1 (3%) 1 (3%)
* difference between LAD segments with and without MB: pb0.0001
b: Relationship between presence of an MB and calcium score adjusted for
confounding factors
Model OR (95% CI)*
Myocardial bridge (yes/no) 1 0.06 (0.01–0.25)†
2 0.05 (0.01–0.22)†
3 0.01 (0.00–0.13)†
4 0.35 (0.04–2.70)
Model 1: Crude.
Model 2: Adjusted for age and gender.
Model 3: Model II additionally adjusted for total coronary artery calcium score.
Model 4: Model II additionally adjusted for local perivascular adipose tissue thickness
of the LAD.
* OR indicates the change in local log-transformed calcium score (0 or >0) in the pres-
ence of a myocardial bridge compared to absence of a myocardial bridge.
† pb0.0001.
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broad range in prevalence reported in the literature (3.5–86%) may
be due to the use of different detection methods, such as autopsy or
angiography, and to the use of different deﬁnitions of MBs [2,2,32].
In CT studies, MBs were detected in 3.5–55% of the study population
[32,33] compared with 44% in our study. Another explanation is
that thinMBs might be taken into account in studies with a high prev-
alence but not in studies with a low prevalence.
In this study with subjects referred for angina pectoris, we con-
ﬁrmed that presence of an MB is not inﬂuenced by age, gender or risk
factors for cardiovascular disease. Also, the point estimate of the rela-
tion between presence of an MB and calcium-score did not change
after adjustment for age and gender. This implicates that MBs inﬂuence
the atherosclerotic process independent from age and gender.
We acknowledge study limitations. Due to the cross-sectional design
it is not possible tomake inferences about causality. Also,weused calcium
score in coronary segments as a surrogate measure of atherosclerosis. Al-
though calcium deposition is highly correlated with atherosclerotic pla-
que burden [34], the calcium content is heterogeneous in different
plaques [35]. Calcium score has a high sensitivity, but amoderate speciﬁc-
ity for predicting the presence of a signiﬁcant stenosis [34]. Outward
remodeling reduces the association between atherosclerosis and vascular
stenosis [36]. Moreover, an increased calcium content of anTable 3
Risk factors for atherosclerosis in relation to the presence of a myocardial bridge (MB)
at any location.
Subjects with MB (n=56) versus
subjects without MB (n=72)
OR (95% CI)
Age (per year) 1.00 (0.95–1.07)
Gender (male) 1.60 (0.74–3.47)
Current smoking (yes) 1.33 (0.59–3.01)a
Diabetes (yes) 0.89 (0.36–2.20)a
BMI (per kg/m2) 0.96 (0.89–1.06)a
LDL-cholesterol (mmol/l) 1.17 (0.83–1.66)a
Triglycerides (mmol/l) 1.24 (0.85–1.83)a
Epicardial adipose tissue volume (per cm3) 1.00 (0.99–1.01)a
Local perivascular adipose tissue of the LAD (per mm2) 0.89 (0.75–1.07)a
Metabolic syndrome (yes) 1.02 (0.49–2.09)a
Number of diseased vessels (0, 1, 2, 3) 1.39 (0.93–2.08)a
Calcium score of the LAD (Agatston) (per 100 U) 0.94 (0.77–1.14)a
Total calcium score (Agatston) (per 100 U) 1.01 (0.95–1.08)a
a Adjusted for age and gender.atherosclerotic plaque is a sign of atherosclerosis of the vascular wall
and not of plaque rupture. For this reason, we also investigated athero-
sclerosis by determining the presence of atherosclerotic plaque.
Information on the presence of plaque conﬁrmed the results obtained
using calcium score. Intravascular ultrasound has been used to detect
MBs and to determine plaque composition [30], and this imaging
method could be used to further explore the role of perivascular adipose
tissue.
In conclusion, in patients with stable and instable angina pectoris,
coronary artery segments covered with an MB have a lower Agatston
calcium score than segments without an MB. The association between
MB and calcium score was inﬂuenced by the thickness of perivascular
adipose tissue adjacent to the coronary artery segment.Acknowledgments
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